SYNT.L

Synthomer plc [SYNT.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

SYNT.L Stock Summary

SYNT.L has more than 2 years of cash runway (33 months)

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

Top 10 Correlated ETFs

SYNT.L

Top 10 Correlated Stocks

SYNT.L

In the News

SYNT.L Financial details

Company Rating

Buy

Market Cap

416.47M

Income

-99.5M

Revenue

4.35B

Book val./share

7.02

Cash/share

2.27

Dividend

Dividend %

Employees

4.2K

Optionable

Shortable

Yes

Earnings

12 Mar 2024

P/E

-30.3

Forward P/E

PEG

-2.92

P/S

0.12

P/B

0.77

P/C

112.33

P/FCF

6.37

Quick Ratio

0.39

Current Ratio

Debt / Equity

0.77

LT Debt / Equity

0.75

EPS (TTM)

-1.04

EPS next Y

EPS next Q

EPS this Y

52.94%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

6.2%

Revenue Q/Q

-16.71%

EPS Q/Q

78.95%

SMA20

31.28%

SMA50

77.78%

SMA100

36.9%

Inst Own

Inst Trans

ROA

-1%

ROE

-3%

ROC

Gross Margin

17%

Oper. Margin

Profit Margin

-1%

Payout

-384%

Shs Outstand

Shs Float

Target Price

52W Range

118.0-970.8403

52W High

-73.71%

52W Low

+116.1%

RSI

Rel Volume

0.38

Avg Volume

855.36K

Volume

328.23K

Perf Week

-1.16%

Perf Month

74.9%

Perf Quarter

43.66%

Perf Half Y

30.77%

Beta

1.782

Volatility

5.61%, 40.34%

Prev Close

2.82%

Price

255

Change

1.19%

SYNT.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	27.32	28.51	36.54	37.58	23.08
Net income per share	1.58	0.05	3.56	-0.51	-0.78
Operating cash flow per share	2.87	3.27	4.69	2.14	1.78
Free cash flow per share	1.58	2.34	3.29	0.71	0.8
Cash per share	1.94	3.5	8.61	3.59	4.35
Book value per share	12.16	10.66	17.37	16.03	13.45
Tangible book value per share	-1.07	-12.77	-4.86	-8.12	2.02
Share holders equity per share	12.16	10.66	17.37	16.03	13.45
Interest debt per share	1.84	12.17	11.21	20.64	11.24
Market cap	1.39B	1.91B	1.73B	673.86M	161.97M
Enterprise value	1.41B	2.43B	1.89B	1.74B	716.97M
P/E ratio	16.45	616.16	8.28	-20.73	-2.42
Price to sales ratio	0.95	1.16	0.81	0.28	0.08
POCF ratio	9.07	10.12	6.27	4.96	1.07
PFCF ratio	16.49	14.16	8.94	14.97	2.39
P/B Ratio	2.14	3.11	1.69	0.66	0.14
PTB ratio	2.14	3.11	1.69	0.66	0.14
EV to sales	0.97	1.48	0.88	0.73	0.36
Enterprise value over EBITDA	7.93	9.44	3.8	7.1	10.61
EV to operating cash flow	9.2	12.86	6.85	12.84	4.72
EV to free cash flow	16.74	17.99	9.76	38.76	10.56
Earnings yield	0.06	0	0.12	-0.05	-0.41
Free cash flow yield	0.06	0.07	0.11	0.07	0.42
Debt to equity	0.14	1.1	0.62	1.24	0.77
Debt to assets	0.07	0.32	0.25	0.4	0.33
Net debt to EBITDA	0.12	2.01	0.32	4.35	8.21
Current ratio	1.41	1.36	1.91	2	1.95
Interest coverage	15.05	5.77	13.63	2.47	-0.49
Income quality	1.81	60.87	1.39	-5.35	-1.48
Dividend Yield	0.03	0.01	0.04	0.15	0
Payout ratio	0.57	4.13	0.35	-3.06	0
Sales general and administrative to revenue	0.04	0.08	0.06	0.04	0.05
Research and developement to revenue	0.01	0.02	0.01	0.01	0.02
Intangibles to total assets	0.58	0.64	0.52	0.49	0.37
Capex to operating cash flow	-0.45	-0.29	-0.3	-0.67	-0.55
Capex to revenue	-0.05	-0.03	-0.04	-0.04	-0.04
Capex to depreciation	-1.14	-0.53	-0.86	-0.69	-0.8
Stock based compensation to revenue	0	0	0	0	0
Graham number	20.82	3.59	37.28	13.59	15.41
ROIC	0.13	-0.02	0.17	0.03	-0.02
Return on tangible assets	0.16	0	0.17	-0.02	-0.04
Graham Net	-5.35	-17.78	-11.23	-23	-9.78
Working capital	122.7M	167.5M	511.5M	581.7M	462.8M
Tangible asset value	-57.1M	-736.3M	-285M	-515.1M	172.7M
Net current asset value	-167.9M	-866.2M	-441.3M	-950.4M	-593.8M
Invested capital	0.14	1.1	0.62	1.24	0.77
Average receivables	190.6M	218.95M	276.7M	299.4M	260.05M
Average payables	195.85M	195.7M	234.3M	258.85M	342.5M
Average inventory	131.9M	146.1M	212M	330.8M	376M
Days sales outstanding	46.28	56.14	51.15	45.67	41.08
Days payables outstanding	54.72	57.12	61.2	44.03	94.63
Days of inventory on hand	35.71	47.54	58.81	70.8	75.5
Receivables turnover	7.89	6.5	7.14	7.99	8.89
Payables turnover	6.67	6.39	5.96	8.29	3.86
Inventory turnover	10.22	7.68	6.21	5.16	4.83
ROE	0.13	0.01	0.2	-0.03	-0.06
Capex per share	-1.29	-0.93	-1.4	-1.43	-0.98

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2021-12-31	2022-06-30	2022-12-31	2023-06-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	17.33	21.03	16.54	16.95	5.48
Net income per share	0.13	1.35	-1.86	-0.19	-0.34
Operating cash flow per share	2.53	-0.58	2.73	0.78	0.63
Free cash flow per share	1.7	-1.11	1.82	0.25	0.32
Cash per share	7.96	4.14	3.59	3.67	2.27
Book value per share	16.07	17.66	16.03	14.98	7.02
Tangible book value per share	-4.49	-12.67	-8.12	-8.02	1.06
Share holders equity per share	16.07	17.66	16.03	14.98	7.02
Interest debt per share	10.12	20.2	20.37	16.97	5.63
Market cap	1.87B	1.05B	673.87M	340.62M	310.29M
Enterprise value	2.03B	2.09B	1.74B	1.19B	865.29M
P/E ratio	55.58	3.08	-1.43	-7.04	-1.41
Price to sales ratio	1.7	0.79	0.64	0.32	0.35
POCF ratio	11.61	-28.34	3.9	6.87	3.03
PFCF ratio	17.34	-14.96	5.84	21.7	5.94
P/B Ratio	1.83	0.94	0.66	0.36	0.27
PTB ratio	1.83	0.94	0.66	0.36	0.27
EV to sales	1.84	1.57	1.66	1.11	0.97
Enterprise value over EBITDA	21.01	11.61	-27.38	18.84	16.17
EV to operating cash flow	12.59	-56.39	10.09	24.08	8.46
EV to free cash flow	18.8	-29.76	15.13	76.08	16.58
Earnings yield	0	0.08	-0.17	-0.04	-0.18
Free cash flow yield	0.06	-0.07	0.17	0.05	0.17
Debt to equity	0.62	1.13	1.24	1.09	0.77
Debt to assets	0.25	0.37	0.4	0.39	0.33
Net debt to EBITDA	1.64	5.77	-16.8	13.47	10.37
Current ratio	1.91	1.6	2	1.72	1.95
Interest coverage	2.96	6.93	-4.71	-0.26	-0.76
Income quality	19.14	-0.43	-1.56	-0.97	-1.98
Dividend Yield	0.04	0	0.15	0	0.02
Payout ratio	8.75	0	-0.84	0	-0.12
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.53	0.57	0.49	0.55	0.37
Capex to operating cash flow	-0.33	0.89	-0.33	-0.68	-0.49
Capex to revenue	-0.05	-0.02	-0.05	-0.03	-0.06
Capex to depreciation	-0.96	-0.52	-0.77	-0.47	-0.62
Stock based compensation to revenue	0	0	0	0	0
Graham number	6.92	23.12	25.89	8.02	7.28
ROIC	0.01	0.04	-0.04	0	-0.01
Return on tangible assets	0.01	0.06	-0.07	-0.01	-0.03
Graham Net	-9.61	-21.34	-23	-17.05	-5.1
Working capital	511.5M	498.9M	581.7M	380.1M	462.8M
Tangible asset value	-285M	-804.1M	-515.1M	-509M	172.7M
Net current asset value	-392.1M	-949.2M	-950.4M	-810.6M	-593.8M
Invested capital	0.62	1.13	1.24	1.09	0.77
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	24.6	36.96	25.58	24.2	22.29
Days payables outstanding	0	50.42	0	37.87	0
Days of inventory on hand	0	41.44	0	32.02	0
Receivables turnover	3.66	2.44	3.52	3.72	4.04
Payables turnover	0	1.79	0	2.38	0
Inventory turnover	0	2.17	0	2.81	0
ROE	0.01	0.08	-0.12	-0.01	-0.05
Capex per share	-0.84	-0.52	-0.91	-0.53	-0.31

SYNT.L Frequently Asked Questions

What is Synthomer plc stock symbol ?

Synthomer plc is a GB stock and trading under the symbol SYNT.L

What is Synthomer plc stock quote today ?

Synthomer plc stock price is $255 today.

Is Synthomer plc stock public?

Yes, Synthomer plc is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 855.36K
Market Capitalization 416.47M
Employee 4.2K
CEO Mr. Michael Willome lic. oec. HSG
Headquarters London,GB
IPO Date 1988-07-01
Website https://www.synthomer.com

Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications. It also provides binders for various carpets; synthetic binders for graphic, packaging, and specialty paper coating applications; paper coating additives and plastic pigments; binders, dispersions, water-based and solvent-borne resins, and other products for various coating applications; foamed bedding products and footwear; elastomeric modifiers for thermoplastics and friction components; reinforcement resins for rubber compounds; and latex for tire cord. In addition, the company offers compounds and aqueous curing pastes for carpets and other applications; acrylic monomers for enhancing the performance characteristics of polymer formulations; antioxidant products; latices for medical examination, clean room, food handling, chemotherapy drug handling, chemical laboratory, and medical device and balloon applications; and nitrile latex, which enhance performance of industrial and fabric-supported gloves. Further, it provides liquid polybutadienes, polyvinyl alcohol suspending agents, polyvinyl acetates, thermosetting resins, butyl ethyl propanediol, and inorganic materials for various industrial applications; and coalescing agents for enhancing the properties of coatings. The company was formerly known as Yule Catto & Co. plc and changed its name to Synthomer plc in 2012. Synthomer plc was founded in 1863 and is headquartered in London, the United Kingdom.